{"id":348122,"date":"2025-08-25T13:58:43","date_gmt":"2025-08-25T13:58:43","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-galectin-therapeutics\/"},"modified":"2025-08-25T13:58:43","modified_gmt":"2025-08-25T13:58:43","slug":"how-to-buy-galectin-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334072,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-348122","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Galectin Therapeutics Inc. (GALT) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Galectin Therapeutics Inc. (GALT)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Galectin Therapeutics Inc. (GALT) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Galectin Therapeutics Inc. (GALT)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, d\u1ef1 b\u00e1o 2025-2030 v\u00e0 chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 t\u1eebng b\u01b0\u1edbc cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, d\u1ef1 b\u00e1o 2025-2030 v\u00e0 chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 t\u1eebng b\u01b0\u1edbc cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ea7y h\u1ee9a h\u1eb9n n\u00e0y."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb b\u1ec7nh gan? Galectin Therapeutics Inc. (GALT) \u0111\u1ea1i di\u1ec7n cho c\u01a1 h\u1ed9i r\u1ee7i ro cao, l\u1ee3i nhu\u1eadn cao \u0111i\u1ec3n h\u00ecnh, thu h\u00fat c\u1ea3 nh\u00e0 \u0111\u1ea7u t\u01b0 k\u1ef3 c\u1ef1u v\u00e0 ng\u01b0\u1eddi m\u1edbi. V\u1edbi thu\u1ed1c ch\u1ee7 l\u1ef1c belapectin cho th\u1ea5y k\u1ebft qu\u1ea3 \u0111\u1ea7y h\u1ee9a h\u1eb9n trong \u0111i\u1ec1u tr\u1ecb x\u01a1 gan MASH, c\u1ed5 phi\u1ebfu $4 n\u00e0y c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh kho\u1ea3n \u0111\u1ea7u t\u01b0 sinh l\u1eddi nhi\u1ec1u l\u1ea7n \u2014 ho\u1eb7c mang l\u1ea1i b\u00e0i h\u1ecdc qu\u00fd gi\u00e1 v\u1ec1 s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 \u0111i\u1ec1u g\u00ec l\u00e0m cho GALT tr\u1edf th\u00e0nh c\u00e2u chuy\u1ec7n h\u1ea5p d\u1eabn trong n\u0103m 2025.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc c\u00f3 th\u1ec3 c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb b\u1ec7nh gan? Galectin Therapeutics Inc. (GALT) \u0111\u1ea1i di\u1ec7n cho c\u01a1 h\u1ed9i r\u1ee7i ro cao, l\u1ee3i nhu\u1eadn cao \u0111i\u1ec3n h\u00ecnh, thu h\u00fat c\u1ea3 nh\u00e0 \u0111\u1ea7u t\u01b0 k\u1ef3 c\u1ef1u v\u00e0 ng\u01b0\u1eddi m\u1edbi. V\u1edbi thu\u1ed1c ch\u1ee7 l\u1ef1c belapectin cho th\u1ea5y k\u1ebft qu\u1ea3 \u0111\u1ea7y h\u1ee9a h\u1eb9n trong \u0111i\u1ec1u tr\u1ecb x\u01a1 gan MASH, c\u1ed5 phi\u1ebfu $4 n\u00e0y c\u00f3 th\u1ec3 tr\u1edf th\u00e0nh kho\u1ea3n \u0111\u1ea7u t\u01b0 sinh l\u1eddi nhi\u1ec1u l\u1ea7n \u2014 ho\u1eb7c mang l\u1ea1i b\u00e0i h\u1ecdc qu\u00fd gi\u00e1 v\u1ec1 s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ee7a ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 \u0111i\u1ec1u g\u00ec l\u00e0m cho GALT tr\u1edf th\u00e0nh c\u00e2u chuy\u1ec7n h\u1ea5p d\u1eabn trong n\u0103m 2025."},"body_html":"<h2>\ud83d\udcc8 Hi\u1ec7u Su\u1ea5t C\u1ed5 Phi\u1ebfu Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Galectin Therapeutics Inc. (GALT) giao d\u1ecbch \u1edf m\u1ee9c <strong>$4.10<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>Th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 th\u1eddi \u0111i\u1ec3m c\u1ef1c k\u1ef3 quan tr\u1ecdng \u2014 c\u00f4ng ty d\u1ef1 ki\u1ebfn s\u1ebd n\u1ed9p h\u1ed3 s\u01a1 belapectin \u0111\u1ec3 xin ph\u00ea duy\u1ec7t FDA.<\/p> <p><strong>C\u00e1ch Quy\u1ebft \u0110\u1ecbnh C\u1ee7a FDA \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu GALT<\/strong><\/p> <p>Xem x\u00e9t l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y, k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng \u0111\u00e3 t\u1ea1o ra nh\u1eefng bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn:<\/p> <ul> <li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: D\u1eef li\u1ec7u s\u01a1 b\u1ed9 th\u1eed nghi\u1ec7m NAVIGATE \u0111\u00e3 khi\u1ebfn c\u1ed5 phi\u1ebfu t\u0103ng <strong>20%<\/strong> ch\u1ec9 sau m\u1ed9t \u0111\u00eam<\/li> <li><strong>Ng\u00e0y 14 th\u00e1ng 8 n\u0103m 2025<\/strong>: B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 2 cho th\u1ea5y gi\u1ea3m l\u1ed7 c\u00f2n $7.6 tri\u1ec7u so v\u1edbi $12.4 tri\u1ec7u c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc, chi ph\u00ed R&D gi\u1ea3m 66% xu\u1ed1ng c\u00f2n $3.3 tri\u1ec7u<\/li> <li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: \u0110\u00e3 \u0111\u1ea3m b\u1ea3o \u0111\u01b0\u1ee3c h\u1ea1n m\u1ee9c t\u00edn d\u1ee5ng 10 tri\u1ec7u \u0111\u00f4 la t\u1eeb ch\u1ee7 t\u1ecbch, k\u00e9o d\u00e0i th\u1eddi gian ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn th\u00e1ng 6 n\u0103m 2026<\/li> <\/ul> <p>M\u00f4 h\u00ecnh r\u00f5 r\u00e0ng: d\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u00edch c\u1ef1c \u0111\u1ea9y GALT t\u0103ng v\u1ecdt, trong khi b\u1ea5t k\u1ef3 tr\u1edf ng\u1ea1i n\u00e0o c\u0169ng g\u00e2y ra s\u1ef1 s\u1ee5t gi\u1ea3m m\u1ea1nh. Vi\u1ec7c n\u1ed9p h\u1ed3 s\u01a1 FDA s\u1eafp t\u1edbi l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn nh\u1ea5t cho \u0111\u1ebfn nay.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u1eeb $1.19 \u0110\u1ebfn $4.10<\/h2> <p>Galectin Therapeutics \u0111\u00e3 mang l\u1ea1i m\u1ee9c t\u0103ng <strong>240%<\/strong> phi th\u01b0\u1eddng trong 6 th\u00e1ng qua, bi\u1ebfn t\u1eeb m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc g\u1eb7p kh\u00f3 kh\u0103n th\u00e0nh m\u1ed9t c\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng \u0111\u1ea7y tri\u1ec3n v\u1ecdng:<\/p> <table> <thead> <tr><th>Th\u00e1ng<\/th><th>Kho\u1ea3ng Gi\u00e1<\/th><th>% Thay \u0110\u1ed5i<\/th><th>Y\u1ebfu T\u1ed1 Ch\u00ednh<\/th><\/tr> <\/thead> <tbody> <tr><td>Th\u00e1ng 3 n\u0103m 2025<\/td><td>$1.19-$1.82<\/td><td>-22.29%<\/td><td>Th\u1ecb tr\u01b0\u1eddng ho\u00e0i nghi<\/td><\/tr> <tr><td>Th\u00e1ng 4 n\u0103m 2025<\/td><td>$1.12-$1.48<\/td><td>+12.30%<\/td><td>L\u1ea1c quan th\u1eed nghi\u1ec7m ban \u0111\u1ea7u<\/td><\/tr> <tr><td>Th\u00e1ng 5 n\u0103m 2025<\/td><td>$1.21-$1.63<\/td><td>-4.38%<\/td><td>Ch\u1ed1t l\u1eddi<\/td><\/tr> <tr><td>Th\u00e1ng 6 n\u0103m 2025<\/td><td>$1.27-$3.90<\/td><td>+61.07%<\/td><td>C\u00f4ng b\u1ed1 d\u1eef li\u1ec7u th\u1eed nghi\u1ec7m NAVIGATE<\/td><\/tr> <tr><td>Th\u00e1ng 7 n\u0103m 2025<\/td><td>$2.07-$3.73<\/td><td>+73.73%<\/td><td>\u0110\u1ea3m b\u1ea3o h\u1ea1n m\u1ee9c t\u00edn d\u1ee5ng<\/td><\/tr> <tr><td>Th\u00e1ng 8 n\u0103m 2025<\/td><td>$3.75-$4.10<\/td><td>+5.67%<\/td><td>B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 2 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng<\/td><\/tr> <\/tbody> <\/table> <p>S\u1ef1 t\u0103ng tr\u01b0\u1edfng b\u00f9ng n\u1ed5 n\u00e0y kh\u00f4ng ph\u1ea3i ng\u1eabu nhi\u00ean \u2014 n\u00f3 \u0111i k\u00e8m v\u1edbi ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng c\u1ee5 th\u1ec3 v\u00e0 qu\u1ea3n l\u00fd t\u00e0i ch\u00ednh c\u1ea3i thi\u1ec7n. C\u00f4ng ty \u0111\u00e3 gi\u1ea3m l\u1ed7 r\u00f2ng 39% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc trong khi v\u1eabn t\u1eadp trung v\u00e0o ch\u01b0\u01a1ng tr\u00ecnh ch\u1ee7 l\u1ef1c.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 c\u00e1c m\u1ed1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng:<\/p> <ul> <li><strong>2025 (Cu\u1ed1i n\u0103m)<\/strong>: M\u1ee5c ti\u00eau $6.00 t\u01b0\u01a1ng \u0111\u01b0\u01a1ng <strong>t\u0103ng 46%<\/strong> so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i. Gi\u1ea3 \u0111\u1ecbnh n\u1ed9p h\u1ed3 s\u01a1 FDA th\u00e0nh c\u00f4ng v\u00e0 d\u1eef li\u1ec7u th\u1eed nghi\u1ec7m ti\u1ebfp t\u1ee5c t\u00edch c\u1ef1c \u2192 <strong>MUA M\u1ea0NH<\/strong><\/li> <li><strong>2026<\/strong>: D\u1ef1 ki\u1ebfn giao d\u1ecbch trong kho\u1ea3ng $1.25-$2.72 n\u1ebfu ph\u00ea duy\u1ec7t FDA b\u1ecb tr\u00ec ho\u00e3n ho\u1eb7c y\u00eau c\u1ea7u th\u1eed nghi\u1ec7m b\u1ed5 sung<\/li> <li><strong>2028<\/strong>: D\u1ef1 ki\u1ebfn gi\u1ea3m xu\u1ed1ng kho\u1ea3ng $1.40-$2.00 do c\u00e1c v\u1ea5n \u0111\u1ec1 v\u1ec1 b\u1eb1ng s\u00e1ng ch\u1ebf v\u00e0 c\u1ea1nh tranh xu\u1ea5t hi\u1ec7n<\/li> <li><strong>2030<\/strong>: R\u1ea5t mang t\u00ednh suy \u0111o\u00e1n \u2014 c\u00f3 th\u1ec3 dao \u0111\u1ed9ng t\u1eeb $0.50 (th\u1ea5t b\u1ea1i) \u0111\u1ebfn tr\u00ean $20 (th\u00e0nh c\u00f4ng \u0111\u1ed9t ph\u00e1) t\u00f9y thu\u1ed9c v\u00e0o m\u1ee9c \u0111\u1ed9 \u00e1p d\u1ee5ng th\u01b0\u01a1ng m\u1ea1i<\/li> <\/ul> <p>S\u1ef1 kh\u00e1c bi\u1ec7t gi\u1eefa l\u1ea1c quan ng\u1eafn h\u1ea1n v\u00e0 b\u1ea5t \u0111\u1ecbnh d\u00e0i h\u1ea1n l\u00e0m n\u1ed5i b\u1eadt t\u00ednh nh\u1ecb ph\u00e2n c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. Hi\u1ec7n t\u1ea1i, c\u00e1c nh\u00e0 ph\u00e2n t\u00edch \u0111\u1ec1u r\u1ea5t l\u1ea1c quan v\u1edbi \u0111\u00e1nh gi\u00e1 <strong>\"Mua M\u1ea1nh\"<\/strong> t\u1eeb t\u1ea5t c\u1ea3 c\u00e1c c\u00f4ng ty theo d\u00f5i.<\/p> <h2>\u26a0\ufe0f Ph\u00e2n T\u00edch R\u1ee7i Ro: Nh\u1eefng \u0110i\u1ec1u C\u00f3 Th\u1ec3 Sai L\u1ea7m?<\/h2> <p><strong>R\u1ee7i Ro Bi\u1ebfn \u0110\u1ed9ng Cao<\/strong><\/p> <ul> <li>Bi\u1ebfn \u0111\u1ed9ng trong ng\u00e0y v\u01b0\u1ee3t qu\u00e1 <strong>13%<\/strong> l\u00e0 ph\u1ed5 bi\u1ebfn<\/li> <li>Tr\u1edf ng\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u00f3 th\u1ec3 x\u00f3a s\u1ea1ch l\u1ee3i nhu\u1eadn nhi\u1ec1u th\u00e1ng ch\u1ec9 trong t\u00edch t\u1eafc<\/li> <li>X\u00e1c su\u1ea5t v\u1ee1 n\u1ee3 t\u0103ng l\u00ean <strong>3.81%<\/strong> v\u00e0o th\u00e1ng 8 n\u0103m 2025<\/li> <\/ul> <p><strong>R\u1ee7i Ro Quy \u0110\u1ecbnh<\/strong><\/p> <ul> <li>FDA t\u1eeb ch\u1ed1i s\u1ebd l\u00e0 th\u1ea3m h\u1ecda cho c\u00f4ng ty ch\u1ec9 c\u00f3 m\u1ed9t t\u00e0i s\u1ea3n n\u00e0y<\/li> <li>Y\u00eau c\u1ea7u th\u1eed nghi\u1ec7m b\u1ed5 sung c\u00f3 th\u1ec3 l\u00e0m c\u1ea1n ki\u1ec7t qu\u1ef9 ti\u1ec1n m\u1eb7t 23.8 tri\u1ec7u \u0111\u00f4 la<\/li> <li>Ph\u00ea duy\u1ec7t ch\u1eadm c\u00f3 th\u1ec3 t\u1ea1o \u0111i\u1ec1u ki\u1ec7n cho \u0111\u1ed1i th\u1ee7 c\u1ea1nh tranh th\u00e2m nh\u1eadp th\u1ecb tr\u01b0\u1eddng MASH<\/li> <\/ul> <p><strong>R\u1ee7i Ro T\u00e0i Ch\u00ednh<\/strong><\/p> <ul> <li>V\u1eabn \u0111ang ti\u00eau ti\u1ec1n m\u1eb7t m\u1eb7c d\u00f9 gi\u1ea3m l\u1ed7 (7.6 tri\u1ec7u \u0111\u00f4 la qu\u00fd tr\u01b0\u1edbc)<\/li> <li>Ph\u1ee5 thu\u1ed9c v\u00e0o t\u00e0i tr\u1ee3 ho\u1eb7c h\u1ee3p t\u00e1c trong t\u01b0\u01a1ng lai \u0111\u1ec3 m\u1edf r\u1ed9ng<\/li> <li>\u0110a d\u1ea1ng doanh thu h\u1ea1n ch\u1ebf ngo\u00e0i belapectin<\/li> <\/ul> <h2>\ud83d\udfe2 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h2> <p><strong>Ti\u1ebfn Tri\u1ec3n L\u00e2m S\u00e0ng<\/strong><\/p> <ul> <li>Th\u1eed nghi\u1ec7m NAVIGATE cho th\u1ea5y hi\u1ec7u qu\u1ea3 b\u1ec1n v\u1eefng trong gi\u1ea3m \u0111\u1ed9 c\u1ee9ng gan<\/li> <li>\u00cdt b\u1ec7nh nh\u00e2n ti\u1ebfn tri\u1ec3n b\u1ec7nh trong nh\u00f3m \u0111i\u1ec1u tr\u1ecb<\/li> <li>K\u1ebft qu\u1ea3 nh\u1ea5t qu\u00e1n sau h\u01a1n 18 th\u00e1ng \u0111i\u1ec1u tr\u1ecb<\/li> <\/ul> <p><strong>C\u1ea3i Thi\u1ec7n T\u00e0i Ch\u00ednh<\/strong><\/p> <ul> <li>Gi\u1ea3m 66% chi ph\u00ed R&D nh\u1edd qu\u1ea3n l\u00fd th\u1eed nghi\u1ec7m hi\u1ec7u qu\u1ea3<\/li> <li>H\u1ea1n m\u1ee9c t\u00edn d\u1ee5ng 10 tri\u1ec7u \u0111\u00f4 la cung c\u1ea5p th\u1eddi gian ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn th\u00e1ng 6 n\u0103m 2026<\/li> <li>Gi\u1ea3m l\u1ed7 r\u00f2ng th\u1ec3 hi\u1ec7n k\u1ef7 lu\u1eadt chi ph\u00ed<\/li> <\/ul> <p><strong>Ti\u1ec1m N\u0103ng Th\u1ecb Tr\u01b0\u1eddng<\/strong><\/p> <ul> <li>X\u01a1 gan MASH l\u00e0 c\u01a1 h\u1ed9i th\u1ecb tr\u01b0\u1eddng tr\u1ecb gi\u00e1 h\u00e0ng t\u1ef7 \u0111\u00f4 la<\/li> <li>L\u1ee3i th\u1ebf ng\u01b0\u1eddi \u0111i \u0111\u1ea7u trong nh\u00f3m b\u1ec7nh nh\u00e2n c\u1ee5 th\u1ec3<\/li> <li>T\u00e2m l\u00fd nh\u00e0 ph\u00e2n t\u00edch m\u1ea1nh m\u1ebd v\u1edbi 100% \u0111\u00e1nh gi\u00e1 \"Mua M\u1ea1nh\"<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f K\u1ebf Ho\u1ea1ch H\u00e0nh \u0110\u1ed9ng Cho Nh\u00e0 Giao D\u1ecbch M\u1edbi H\u00f4m Nay<\/h2> <ol> <li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-3% danh m\u1ee5c cho c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao nh\u01b0 GALT<\/li> <li><strong>Trung B\u00ecnh Gi\u00e1<\/strong>: Thay v\u00ec mua m\u1ed9t l\u1ea7n l\u1edbn, h\u00e3y mua t\u1eebng ph\u1ea7n quanh c\u00e1c ng\u00e0y quan tr\u1ecdng (tr\u01b0\u1edbc n\u1ed9p h\u1ed3 s\u01a1 FDA, sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn)<\/li> <li><strong>\u0110\u1eb7t L\u1ec7nh C\u1eaft L\u1ed7<\/strong>: B\u1ea3o v\u1ec7 v\u1ed1n v\u1edbi l\u1ec7nh c\u1eaft l\u1ed7 15-20% do bi\u1ebfn \u0111\u1ed9ng cao<\/li> <li><strong>Theo D\u00f5i Ch\u1ea5t X\u00fac T\u00e1c<\/strong>: Ch\u00fa \u00fd tin t\u1ee9c n\u1ed9p h\u1ed3 s\u01a1 FDA th\u00e1ng 11 v\u00e0 c\u00e1c th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c<\/li> <\/ol> <p>Ch\u00e2m bi\u1ebfm: \"Giao d\u1ecbch GALT gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba \u2014 c\u1ef1c k\u1ef3 th\u00fa v\u1ecb khi c\u00e1c th\u00ed nghi\u1ec7m th\u00e0nh c\u00f4ng, nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb cho nh\u1eefng ph\u1ea3n \u1ee9ng n\u1ed5 khi ch\u00fang th\u1ea5t b\u1ea1i!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Galectin Therapeutics Inc. (GALT) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf do bi\u1ebfn \u0111\u1ed9ng cao<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm m\u00e3 \"GALT\"<\/td><td>D\u00f9ng \u0111\u00fang k\u00fd hi\u1ec7u, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>4<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o trong c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng<\/td><\/tr> <tr><td>5<\/td><td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td><td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng \u2014 m\u1ee5c ti\u00eau d\u01b0\u1edbi 1% cho giao d\u1ecbch nh\u1ecf<\/td><\/tr> <tr><td>6<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/td><td>Theo d\u00f5i tin FDA v\u00e0 th\u00f4ng b\u00e1o l\u1ee3i nhu\u1eadn<\/td><\/tr> <tr><td>7<\/td><td>L\u1eadp k\u1ebf ho\u1ea1ch tho\u00e1t<\/td><td>Quy\u1ebft \u0111\u1ecbnh tr\u01b0\u1edbc m\u1ee9c ch\u1ed1t l\u1eddi v\u00e0 c\u1eaft l\u1ed7<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Thu H\u00fat Nh\u00e0 \u0110\u1ea7u T\u01b0 C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc M\u1edbi<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi quan t\u00e2m \u0111\u1ebfn c\u00e1c c\u00f4ng ty nh\u01b0 Galectin Therapeutics, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p> <ul> <li><strong>Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u<\/strong>: Ch\u1ec9 <strong>$5<\/strong> cho ph\u00e9p b\u1ea1n th\u1eed nghi\u1ec7m l\u00fd thuy\u1ebft \u0111\u1ea7u t\u01b0 m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn \u2014 l\u00fd t\u01b0\u1edfng \u0111\u1ec3 h\u1ecdc c\u00e1ch bi\u1ebfn \u0111\u1ed9ng c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <li><strong>X\u00e1c Minh Nhanh<\/strong>: Quy tr\u00ecnh KYC 1 ph\u00fat v\u1edbi b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd n\u00e0o gi\u00fap b\u1ea1n ph\u1ea3n \u1ee9ng nhanh v\u1edbi tin t\u1ee9c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng m\u1edbi<\/li> <li><strong>Nhi\u1ec1u Ph\u01b0\u01a1ng Th\u1ee9c R\u00fat Ti\u1ec1n<\/strong>: H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng \u2014 quan tr\u1ecdng khi b\u1ea1n c\u1ea7n b\u1ea3o to\u00e0n l\u1ee3i nhu\u1eadn c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nhanh ch\u00f3ng<\/li> <\/ul> <p>N\u1ec1n t\u1ea3ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p gi\u00fap b\u1ea1n x\u00e2y d\u1ef1ng s\u1ef1 t\u1ef1 tin tr\u01b0\u1edbc khi cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn v\u00e0o c\u00e1c l\u0129nh v\u1ef1c bi\u1ebfn \u0111\u1ed9ng nh\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p> <h2>\ud83c\udf0d Galectin Therapeutics N\u0103m 2025: V\u1ecb Th\u1ebf v\u00e0 Ti\u1ec1m N\u0103ng<\/h2> <p>Galectin Therapeutics ho\u1ea1t \u0111\u1ed9ng trong th\u1ecb tr\u01b0\u1eddng \u0111i\u1ec1u tr\u1ecb MASH (Vi\u00eam gan nhi\u1ec5m m\u1ee1 li\u00ean quan \u0111\u1ebfn r\u1ed1i lo\u1ea1n chuy\u1ec3n h\u00f3a) c\u1ea1nh tranh kh\u1ed1c li\u1ec7t nh\u01b0ng \u0111\u1ea7y ti\u1ec1m n\u0103ng. C\u00f4ng ty t\u1eadp trung v\u00e0o \u1ee9c ch\u1ebf galectin-3, m\u1ed9t ph\u01b0\u01a1ng ph\u00e1p m\u1edbi trong \u0111i\u1ec1u tr\u1ecb x\u01a1 gan v\u00e0 x\u01a1 h\u00f3a gan.<\/p> <p>Hi\u1ec7n \u0111\u01b0\u1ee3c \u0111\u1ecbnh gi\u00e1 kho\u1ea3ng 262 tri\u1ec7u \u0111\u00f4 la, Galectin l\u00e0 c\u00e2u chuy\u1ec7n \"\u0111\u01b0\u1eddng \u1ed1ng\" \u0111i\u1ec3n h\u00ecnh, n\u01a1i v\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng ph\u1ea3n \u00e1nh ti\u1ec1m n\u0103ng h\u01a1n l\u00e0 doanh thu hi\u1ec7n t\u1ea1i. To\u00e0n b\u1ed9 gi\u00e1 tr\u1ecb c\u00f4ng ty ph\u1ee5 thu\u1ed9c v\u00e0o th\u00e0nh c\u00f4ng c\u1ee7a belapectin, t\u1ea1o ra c\u1ea3 c\u01a1 h\u1ed9i l\u1edbn v\u00e0 r\u1ee7i ro \u0111\u00e1ng k\u1ec3.<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb N\u0103m 2025<\/strong>: Ch\u1ee7 t\u1ecbch Richard E. Uihlein c\u1ee7a Galectin \u0111\u00e3 c\u00e1 nh\u00e2n cung c\u1ea5p h\u1ea1n m\u1ee9c t\u00edn d\u1ee5ng 10 tri\u1ec7u \u0111\u00f4 la v\u00e0o th\u00e1ng 7 n\u0103m 2025 \u2014 m\u1ed9t s\u1ef1 b\u1ea7u ch\u1ecdn m\u1ea1nh m\u1ebd v\u1ec1 ni\u1ec1m tin t\u1eeb ng\u01b0\u1eddi hi\u1ec3u r\u00f5 tri\u1ec3n v\u1ecdng v\u00e0 th\u00e1ch th\u1ee9c c\u1ee7a c\u00f4ng ty.<\/p> <table> <thead> <tr><th>Ch\u1ec9 S\u1ed1<\/th><th>Gi\u00e1 Tr\u1ecb<\/th><th>\u00dd Ngh\u0129a<\/th><\/tr> <\/thead> <tbody> <tr><td>Gi\u00e1 Hi\u1ec7n T\u1ea1i<\/td><td>$4.10<\/td><td>T\u0103ng 240% t\u1eeb m\u1ee9c th\u1ea5p th\u00e1ng 3<\/td><\/tr> <tr><td>V\u1ed1n H\u00f3a Th\u1ecb Tr\u01b0\u1eddng<\/td><td>$262M<\/td><td>\u0110i\u1ec3n h\u00ecnh cho c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng<\/td><\/tr> <tr><td>Th\u1eddi Gian Ho\u1ea1t \u0110\u1ed9ng Ti\u1ec1n M\u1eb7t<\/td><td>\u0110\u1ebfn th\u00e1ng 6 n\u0103m 2026<\/td><td>\u0110\u1ee7 cho ho\u1ea1t \u0111\u1ed9ng ng\u1eafn h\u1ea1n<\/td><\/tr> <tr><td>M\u1ee5c Ti\u00eau Nh\u00e0 Ph\u00e2n T\u00edch<\/td><td>$6.00<\/td><td>Ti\u1ec1m n\u0103ng t\u0103ng 46%<\/td><\/tr> <tr><td>Kh\u1ed1i L\u01b0\u1ee3ng Giao D\u1ecbch H\u00e0ng Ng\u00e0y<\/td><td>253,780 c\u1ed5 phi\u1ebfu<\/td><td>Thanh kho\u1ea3n \u0111\u1ee7 cho nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00e1 nh\u00e2n<\/td><\/tr> <\/tbody> <\/table>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Hi\u1ec7u Su\u1ea5t C\u1ed5 Phi\u1ebfu Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Galectin Therapeutics Inc. (GALT) giao d\u1ecbch \u1edf m\u1ee9c <strong>$4.10<\/strong> tr\u00ean NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>Th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 th\u1eddi \u0111i\u1ec3m c\u1ef1c k\u1ef3 quan tr\u1ecdng \u2014 c\u00f4ng ty d\u1ef1 ki\u1ebfn s\u1ebd n\u1ed9p h\u1ed3 s\u01a1 belapectin \u0111\u1ec3 xin ph\u00ea duy\u1ec7t FDA.<\/p>\n<p><strong>C\u00e1ch Quy\u1ebft \u0110\u1ecbnh C\u1ee7a FDA \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu GALT<\/strong><\/p>\n<p>Xem x\u00e9t l\u1ecbch s\u1eed g\u1ea7n \u0111\u00e2y, k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng \u0111\u00e3 t\u1ea1o ra nh\u1eefng bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 6 n\u0103m 2025<\/strong>: D\u1eef li\u1ec7u s\u01a1 b\u1ed9 th\u1eed nghi\u1ec7m NAVIGATE \u0111\u00e3 khi\u1ebfn c\u1ed5 phi\u1ebfu t\u0103ng <strong>20%<\/strong> ch\u1ec9 sau m\u1ed9t \u0111\u00eam<\/li>\n<li><strong>Ng\u00e0y 14 th\u00e1ng 8 n\u0103m 2025<\/strong>: B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 2 cho th\u1ea5y gi\u1ea3m l\u1ed7 c\u00f2n $7.6 tri\u1ec7u so v\u1edbi $12.4 tri\u1ec7u c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc, chi ph\u00ed R&#038;D gi\u1ea3m 66% xu\u1ed1ng c\u00f2n $3.3 tri\u1ec7u<\/li>\n<li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: \u0110\u00e3 \u0111\u1ea3m b\u1ea3o \u0111\u01b0\u1ee3c h\u1ea1n m\u1ee9c t\u00edn d\u1ee5ng 10 tri\u1ec7u \u0111\u00f4 la t\u1eeb ch\u1ee7 t\u1ecbch, k\u00e9o d\u00e0i th\u1eddi gian ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn th\u00e1ng 6 n\u0103m 2026<\/li>\n<\/ul>\n<p>M\u00f4 h\u00ecnh r\u00f5 r\u00e0ng: d\u1eef li\u1ec7u l\u00e2m s\u00e0ng t\u00edch c\u1ef1c \u0111\u1ea9y GALT t\u0103ng v\u1ecdt, trong khi b\u1ea5t k\u1ef3 tr\u1edf ng\u1ea1i n\u00e0o c\u0169ng g\u00e2y ra s\u1ef1 s\u1ee5t gi\u1ea3m m\u1ea1nh. Vi\u1ec7c n\u1ed9p h\u1ed3 s\u01a1 FDA s\u1eafp t\u1edbi l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn nh\u1ea5t cho \u0111\u1ebfn nay.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u1eeb $1.19 \u0110\u1ebfn $4.10<\/h2>\n<p>Galectin Therapeutics \u0111\u00e3 mang l\u1ea1i m\u1ee9c t\u0103ng <strong>240%<\/strong> phi th\u01b0\u1eddng trong 6 th\u00e1ng qua, bi\u1ebfn t\u1eeb m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc g\u1eb7p kh\u00f3 kh\u0103n th\u00e0nh m\u1ed9t c\u00f4ng ty giai \u0111o\u1ea1n l\u00e2m s\u00e0ng \u0111\u1ea7y tri\u1ec3n v\u1ecdng:<\/p>\n<table>\n<thead>\n<tr>\n<th>Th\u00e1ng<\/th>\n<th>Kho\u1ea3ng Gi\u00e1<\/th>\n<th>% Thay \u0110\u1ed5i<\/th>\n<th>Y\u1ebfu T\u1ed1 Ch\u00ednh<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Th\u00e1ng 3 n\u0103m 2025<\/td>\n<td>$1.19-$1.82<\/td>\n<td>-22.29%<\/td>\n<td>Th\u1ecb tr\u01b0\u1eddng ho\u00e0i nghi<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 4 n\u0103m 2025<\/td>\n<td>$1.12-$1.48<\/td>\n<td>+12.30%<\/td>\n<td>L\u1ea1c quan th\u1eed nghi\u1ec7m ban \u0111\u1ea7u<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 5 n\u0103m 2025<\/td>\n<td>$1.21-$1.63<\/td>\n<td>-4.38%<\/td>\n<td>Ch\u1ed1t l\u1eddi<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 6 n\u0103m 2025<\/td>\n<td>$1.27-$3.90<\/td>\n<td>+61.07%<\/td>\n<td>C\u00f4ng b\u1ed1 d\u1eef li\u1ec7u th\u1eed nghi\u1ec7m NAVIGATE<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 7 n\u0103m 2025<\/td>\n<td>$2.07-$3.73<\/td>\n<td>+73.73%<\/td>\n<td>\u0110\u1ea3m b\u1ea3o h\u1ea1n m\u1ee9c t\u00edn d\u1ee5ng<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 8 n\u0103m 2025<\/td>\n<td>$3.75-$4.10<\/td>\n<td>+5.67%<\/td>\n<td>B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 2 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>S\u1ef1 t\u0103ng tr\u01b0\u1edfng b\u00f9ng n\u1ed5 n\u00e0y kh\u00f4ng ph\u1ea3i ng\u1eabu nhi\u00ean \u2014 n\u00f3 \u0111i k\u00e8m v\u1edbi ti\u1ebfn tri\u1ec3n l\u00e2m s\u00e0ng c\u1ee5 th\u1ec3 v\u00e0 qu\u1ea3n l\u00fd t\u00e0i ch\u00ednh c\u1ea3i thi\u1ec7n. C\u00f4ng ty \u0111\u00e3 gi\u1ea3m l\u1ed7 r\u00f2ng 39% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc trong khi v\u1eabn t\u1eadp trung v\u00e0o ch\u01b0\u01a1ng tr\u00ecnh ch\u1ee7 l\u1ef1c.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch hi\u1ec7n t\u1ea1i v\u00e0 c\u00e1c m\u1ed1c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng:<\/p>\n<ul>\n<li><strong>2025 (Cu\u1ed1i n\u0103m)<\/strong>: M\u1ee5c ti\u00eau $6.00 t\u01b0\u01a1ng \u0111\u01b0\u01a1ng <strong>t\u0103ng 46%<\/strong> so v\u1edbi m\u1ee9c hi\u1ec7n t\u1ea1i. Gi\u1ea3 \u0111\u1ecbnh n\u1ed9p h\u1ed3 s\u01a1 FDA th\u00e0nh c\u00f4ng v\u00e0 d\u1eef li\u1ec7u th\u1eed nghi\u1ec7m ti\u1ebfp t\u1ee5c t\u00edch c\u1ef1c \u2192 <strong>MUA M\u1ea0NH<\/strong><\/li>\n<li><strong>2026<\/strong>: D\u1ef1 ki\u1ebfn giao d\u1ecbch trong kho\u1ea3ng $1.25-$2.72 n\u1ebfu ph\u00ea duy\u1ec7t FDA b\u1ecb tr\u00ec ho\u00e3n ho\u1eb7c y\u00eau c\u1ea7u th\u1eed nghi\u1ec7m b\u1ed5 sung<\/li>\n<li><strong>2028<\/strong>: D\u1ef1 ki\u1ebfn gi\u1ea3m xu\u1ed1ng kho\u1ea3ng $1.40-$2.00 do c\u00e1c v\u1ea5n \u0111\u1ec1 v\u1ec1 b\u1eb1ng s\u00e1ng ch\u1ebf v\u00e0 c\u1ea1nh tranh xu\u1ea5t hi\u1ec7n<\/li>\n<li><strong>2030<\/strong>: R\u1ea5t mang t\u00ednh suy \u0111o\u00e1n \u2014 c\u00f3 th\u1ec3 dao \u0111\u1ed9ng t\u1eeb $0.50 (th\u1ea5t b\u1ea1i) \u0111\u1ebfn tr\u00ean $20 (th\u00e0nh c\u00f4ng \u0111\u1ed9t ph\u00e1) t\u00f9y thu\u1ed9c v\u00e0o m\u1ee9c \u0111\u1ed9 \u00e1p d\u1ee5ng th\u01b0\u01a1ng m\u1ea1i<\/li>\n<\/ul>\n<p>S\u1ef1 kh\u00e1c bi\u1ec7t gi\u1eefa l\u1ea1c quan ng\u1eafn h\u1ea1n v\u00e0 b\u1ea5t \u0111\u1ecbnh d\u00e0i h\u1ea1n l\u00e0m n\u1ed5i b\u1eadt t\u00ednh nh\u1ecb ph\u00e2n c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc. Hi\u1ec7n t\u1ea1i, c\u00e1c nh\u00e0 ph\u00e2n t\u00edch \u0111\u1ec1u r\u1ea5t l\u1ea1c quan v\u1edbi \u0111\u00e1nh gi\u00e1 <strong>&#8220;Mua M\u1ea1nh&#8221;<\/strong> t\u1eeb t\u1ea5t c\u1ea3 c\u00e1c c\u00f4ng ty theo d\u00f5i.<\/p>\n<h2>\u26a0\ufe0f Ph\u00e2n T\u00edch R\u1ee7i Ro: Nh\u1eefng \u0110i\u1ec1u C\u00f3 Th\u1ec3 Sai L\u1ea7m?<\/h2>\n<p><strong>R\u1ee7i Ro Bi\u1ebfn \u0110\u1ed9ng Cao<\/strong><\/p>\n<ul>\n<li>Bi\u1ebfn \u0111\u1ed9ng trong ng\u00e0y v\u01b0\u1ee3t qu\u00e1 <strong>13%<\/strong> l\u00e0 ph\u1ed5 bi\u1ebfn<\/li>\n<li>Tr\u1edf ng\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u00f3 th\u1ec3 x\u00f3a s\u1ea1ch l\u1ee3i nhu\u1eadn nhi\u1ec1u th\u00e1ng ch\u1ec9 trong t\u00edch t\u1eafc<\/li>\n<li>X\u00e1c su\u1ea5t v\u1ee1 n\u1ee3 t\u0103ng l\u00ean <strong>3.81%<\/strong> v\u00e0o th\u00e1ng 8 n\u0103m 2025<\/li>\n<\/ul>\n<p><strong>R\u1ee7i Ro Quy \u0110\u1ecbnh<\/strong><\/p>\n<ul>\n<li>FDA t\u1eeb ch\u1ed1i s\u1ebd l\u00e0 th\u1ea3m h\u1ecda cho c\u00f4ng ty ch\u1ec9 c\u00f3 m\u1ed9t t\u00e0i s\u1ea3n n\u00e0y<\/li>\n<li>Y\u00eau c\u1ea7u th\u1eed nghi\u1ec7m b\u1ed5 sung c\u00f3 th\u1ec3 l\u00e0m c\u1ea1n ki\u1ec7t qu\u1ef9 ti\u1ec1n m\u1eb7t 23.8 tri\u1ec7u \u0111\u00f4 la<\/li>\n<li>Ph\u00ea duy\u1ec7t ch\u1eadm c\u00f3 th\u1ec3 t\u1ea1o \u0111i\u1ec1u ki\u1ec7n cho \u0111\u1ed1i th\u1ee7 c\u1ea1nh tranh th\u00e2m nh\u1eadp th\u1ecb tr\u01b0\u1eddng MASH<\/li>\n<\/ul>\n<p><strong>R\u1ee7i Ro T\u00e0i Ch\u00ednh<\/strong><\/p>\n<ul>\n<li>V\u1eabn \u0111ang ti\u00eau ti\u1ec1n m\u1eb7t m\u1eb7c d\u00f9 gi\u1ea3m l\u1ed7 (7.6 tri\u1ec7u \u0111\u00f4 la qu\u00fd tr\u01b0\u1edbc)<\/li>\n<li>Ph\u1ee5 thu\u1ed9c v\u00e0o t\u00e0i tr\u1ee3 ho\u1eb7c h\u1ee3p t\u00e1c trong t\u01b0\u01a1ng lai \u0111\u1ec3 m\u1edf r\u1ed9ng<\/li>\n<li>\u0110a d\u1ea1ng doanh thu h\u1ea1n ch\u1ebf ngo\u00e0i belapectin<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h2>\n<p><strong>Ti\u1ebfn Tri\u1ec3n L\u00e2m S\u00e0ng<\/strong><\/p>\n<ul>\n<li>Th\u1eed nghi\u1ec7m NAVIGATE cho th\u1ea5y hi\u1ec7u qu\u1ea3 b\u1ec1n v\u1eefng trong gi\u1ea3m \u0111\u1ed9 c\u1ee9ng gan<\/li>\n<li>\u00cdt b\u1ec7nh nh\u00e2n ti\u1ebfn tri\u1ec3n b\u1ec7nh trong nh\u00f3m \u0111i\u1ec1u tr\u1ecb<\/li>\n<li>K\u1ebft qu\u1ea3 nh\u1ea5t qu\u00e1n sau h\u01a1n 18 th\u00e1ng \u0111i\u1ec1u tr\u1ecb<\/li>\n<\/ul>\n<p><strong>C\u1ea3i Thi\u1ec7n T\u00e0i Ch\u00ednh<\/strong><\/p>\n<ul>\n<li>Gi\u1ea3m 66% chi ph\u00ed R&#038;D nh\u1edd qu\u1ea3n l\u00fd th\u1eed nghi\u1ec7m hi\u1ec7u qu\u1ea3<\/li>\n<li>H\u1ea1n m\u1ee9c t\u00edn d\u1ee5ng 10 tri\u1ec7u \u0111\u00f4 la cung c\u1ea5p th\u1eddi gian ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn th\u00e1ng 6 n\u0103m 2026<\/li>\n<li>Gi\u1ea3m l\u1ed7 r\u00f2ng th\u1ec3 hi\u1ec7n k\u1ef7 lu\u1eadt chi ph\u00ed<\/li>\n<\/ul>\n<p><strong>Ti\u1ec1m N\u0103ng Th\u1ecb Tr\u01b0\u1eddng<\/strong><\/p>\n<ul>\n<li>X\u01a1 gan MASH l\u00e0 c\u01a1 h\u1ed9i th\u1ecb tr\u01b0\u1eddng tr\u1ecb gi\u00e1 h\u00e0ng t\u1ef7 \u0111\u00f4 la<\/li>\n<li>L\u1ee3i th\u1ebf ng\u01b0\u1eddi \u0111i \u0111\u1ea7u trong nh\u00f3m b\u1ec7nh nh\u00e2n c\u1ee5 th\u1ec3<\/li>\n<li>T\u00e2m l\u00fd nh\u00e0 ph\u00e2n t\u00edch m\u1ea1nh m\u1ebd v\u1edbi 100% \u0111\u00e1nh gi\u00e1 &#8220;Mua M\u1ea1nh&#8221;<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f K\u1ebf Ho\u1ea1ch H\u00e0nh \u0110\u1ed9ng Cho Nh\u00e0 Giao D\u1ecbch M\u1edbi H\u00f4m Nay<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-3% danh m\u1ee5c cho c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao nh\u01b0 GALT<\/li>\n<li><strong>Trung B\u00ecnh Gi\u00e1<\/strong>: Thay v\u00ec mua m\u1ed9t l\u1ea7n l\u1edbn, h\u00e3y mua t\u1eebng ph\u1ea7n quanh c\u00e1c ng\u00e0y quan tr\u1ecdng (tr\u01b0\u1edbc n\u1ed9p h\u1ed3 s\u01a1 FDA, sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn)<\/li>\n<li><strong>\u0110\u1eb7t L\u1ec7nh C\u1eaft L\u1ed7<\/strong>: B\u1ea3o v\u1ec7 v\u1ed1n v\u1edbi l\u1ec7nh c\u1eaft l\u1ed7 15-20% do bi\u1ebfn \u0111\u1ed9ng cao<\/li>\n<li><strong>Theo D\u00f5i Ch\u1ea5t X\u00fac T\u00e1c<\/strong>: Ch\u00fa \u00fd tin t\u1ee9c n\u1ed9p h\u1ed3 s\u01a1 FDA th\u00e1ng 11 v\u00e0 c\u00e1c th\u00f4ng b\u00e1o h\u1ee3p t\u00e1c<\/li>\n<\/ol>\n<p>Ch\u00e2m bi\u1ebfm: &#8220;Giao d\u1ecbch GALT gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba \u2014 c\u1ef1c k\u1ef3 th\u00fa v\u1ecb khi c\u00e1c th\u00ed nghi\u1ec7m th\u00e0nh c\u00f4ng, nh\u01b0ng h\u00e3y chu\u1ea9n b\u1ecb cho nh\u1eefng ph\u1ea3n \u1ee9ng n\u1ed5 khi ch\u00fang th\u1ea5t b\u1ea1i!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Galectin Therapeutics Inc. (GALT) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n nh\u1ecf do bi\u1ebfn \u0111\u1ed9ng cao<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm m\u00e3 &#8220;GALT&#8221;<\/td>\n<td>D\u00f9ng \u0111\u00fang k\u00fd hi\u1ec7u, kh\u00f4ng ch\u1ec9 t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o trong c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng \u2014 m\u1ee5c ti\u00eau d\u01b0\u1edbi 1% cho giao d\u1ecbch nh\u1ecf<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/td>\n<td>Theo d\u00f5i tin FDA v\u00e0 th\u00f4ng b\u00e1o l\u1ee3i nhu\u1eadn<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>L\u1eadp k\u1ebf ho\u1ea1ch tho\u00e1t<\/td>\n<td>Quy\u1ebft \u0111\u1ecbnh tr\u01b0\u1edbc m\u1ee9c ch\u1ed1t l\u1eddi v\u00e0 c\u1eaft l\u1ed7<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Thu H\u00fat Nh\u00e0 \u0110\u1ea7u T\u01b0 C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc M\u1edbi<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ng\u01b0\u1eddi quan t\u00e2m \u0111\u1ebfn c\u00e1c c\u00f4ng ty nh\u01b0 Galectin Therapeutics, Pocket Option cung c\u1ea5p nhi\u1ec1u l\u1ee3i th\u1ebf:<\/p>\n<ul>\n<li><strong>Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u<\/strong>: Ch\u1ec9 <strong>$5<\/strong> cho ph\u00e9p b\u1ea1n th\u1eed nghi\u1ec7m l\u00fd thuy\u1ebft \u0111\u1ea7u t\u01b0 m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn \u2014 l\u00fd t\u01b0\u1edfng \u0111\u1ec3 h\u1ecdc c\u00e1ch bi\u1ebfn \u0111\u1ed9ng c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<li><strong>X\u00e1c Minh Nhanh<\/strong>: Quy tr\u00ecnh KYC 1 ph\u00fat v\u1edbi b\u1ea5t k\u1ef3 gi\u1ea5y t\u1edd n\u00e0o gi\u00fap b\u1ea1n ph\u1ea3n \u1ee9ng nhanh v\u1edbi tin t\u1ee9c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng m\u1edbi<\/li>\n<li><strong>Nhi\u1ec1u Ph\u01b0\u01a1ng Th\u1ee9c R\u00fat Ti\u1ec1n<\/strong>: H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng \u2014 quan tr\u1ecdng khi b\u1ea1n c\u1ea7n b\u1ea3o to\u00e0n l\u1ee3i nhu\u1eadn c\u00f4ng ngh\u1ec7 sinh h\u1ecdc nhanh ch\u00f3ng<\/li>\n<\/ul>\n<p>N\u1ec1n t\u1ea3ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p gi\u00fap b\u1ea1n x\u00e2y d\u1ef1ng s\u1ef1 t\u1ef1 tin tr\u01b0\u1edbc khi cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn v\u00e0o c\u00e1c l\u0129nh v\u1ef1c bi\u1ebfn \u0111\u1ed9ng nh\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>\n<h2>\ud83c\udf0d Galectin Therapeutics N\u0103m 2025: V\u1ecb Th\u1ebf v\u00e0 Ti\u1ec1m N\u0103ng<\/h2>\n<p>Galectin Therapeutics ho\u1ea1t \u0111\u1ed9ng trong th\u1ecb tr\u01b0\u1eddng \u0111i\u1ec1u tr\u1ecb MASH (Vi\u00eam gan nhi\u1ec5m m\u1ee1 li\u00ean quan \u0111\u1ebfn r\u1ed1i lo\u1ea1n chuy\u1ec3n h\u00f3a) c\u1ea1nh tranh kh\u1ed1c li\u1ec7t nh\u01b0ng \u0111\u1ea7y ti\u1ec1m n\u0103ng. C\u00f4ng ty t\u1eadp trung v\u00e0o \u1ee9c ch\u1ebf galectin-3, m\u1ed9t ph\u01b0\u01a1ng ph\u00e1p m\u1edbi trong \u0111i\u1ec1u tr\u1ecb x\u01a1 gan v\u00e0 x\u01a1 h\u00f3a gan.<\/p>\n<p>Hi\u1ec7n \u0111\u01b0\u1ee3c \u0111\u1ecbnh gi\u00e1 kho\u1ea3ng 262 tri\u1ec7u \u0111\u00f4 la, Galectin l\u00e0 c\u00e2u chuy\u1ec7n &#8220;\u0111\u01b0\u1eddng \u1ed1ng&#8221; \u0111i\u1ec3n h\u00ecnh, n\u01a1i v\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng ph\u1ea3n \u00e1nh ti\u1ec1m n\u0103ng h\u01a1n l\u00e0 doanh thu hi\u1ec7n t\u1ea1i. To\u00e0n b\u1ed9 gi\u00e1 tr\u1ecb c\u00f4ng ty ph\u1ee5 thu\u1ed9c v\u00e0o th\u00e0nh c\u00f4ng c\u1ee7a belapectin, t\u1ea1o ra c\u1ea3 c\u01a1 h\u1ed9i l\u1edbn v\u00e0 r\u1ee7i ro \u0111\u00e1ng k\u1ec3.<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb N\u0103m 2025<\/strong>: Ch\u1ee7 t\u1ecbch Richard E. Uihlein c\u1ee7a Galectin \u0111\u00e3 c\u00e1 nh\u00e2n cung c\u1ea5p h\u1ea1n m\u1ee9c t\u00edn d\u1ee5ng 10 tri\u1ec7u \u0111\u00f4 la v\u00e0o th\u00e1ng 7 n\u0103m 2025 \u2014 m\u1ed9t s\u1ef1 b\u1ea7u ch\u1ecdn m\u1ea1nh m\u1ebd v\u1ec1 ni\u1ec1m tin t\u1eeb ng\u01b0\u1eddi hi\u1ec3u r\u00f5 tri\u1ec3n v\u1ecdng v\u00e0 th\u00e1ch th\u1ee9c c\u1ee7a c\u00f4ng ty.<\/p>\n<table>\n<thead>\n<tr>\n<th>Ch\u1ec9 S\u1ed1<\/th>\n<th>Gi\u00e1 Tr\u1ecb<\/th>\n<th>\u00dd Ngh\u0129a<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Gi\u00e1 Hi\u1ec7n T\u1ea1i<\/td>\n<td>$4.10<\/td>\n<td>T\u0103ng 240% t\u1eeb m\u1ee9c th\u1ea5p th\u00e1ng 3<\/td>\n<\/tr>\n<tr>\n<td>V\u1ed1n H\u00f3a Th\u1ecb Tr\u01b0\u1eddng<\/td>\n<td>$262M<\/td>\n<td>\u0110i\u1ec3n h\u00ecnh cho c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc giai \u0111o\u1ea1n l\u00e2m s\u00e0ng<\/td>\n<\/tr>\n<tr>\n<td>Th\u1eddi Gian Ho\u1ea1t \u0110\u1ed9ng Ti\u1ec1n M\u1eb7t<\/td>\n<td>\u0110\u1ebfn th\u00e1ng 6 n\u0103m 2026<\/td>\n<td>\u0110\u1ee7 cho ho\u1ea1t \u0111\u1ed9ng ng\u1eafn h\u1ea1n<\/td>\n<\/tr>\n<tr>\n<td>M\u1ee5c Ti\u00eau Nh\u00e0 Ph\u00e2n T\u00edch<\/td>\n<td>$6.00<\/td>\n<td>Ti\u1ec1m n\u0103ng t\u0103ng 46%<\/td>\n<\/tr>\n<tr>\n<td>Kh\u1ed1i L\u01b0\u1ee3ng Giao D\u1ecbch H\u00e0ng Ng\u00e0y<\/td>\n<td>253,780 c\u1ed5 phi\u1ebfu<\/td>\n<td>Thanh kho\u1ea3n \u0111\u1ee7 cho nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00e1 nh\u00e2n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu GALT th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n h\u1ed7 tr\u1ee3 NASDAQ. H\u00e3y ch\u1ecdn n\u1ec1n t\u1ea3ng uy t\u00edn, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu \"GALT\", \u0111\u1eb7t l\u1ec7nh mua v\u1edbi lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 theo d\u00f5i c\u00e1c tin t\u1ee9c li\u00ean quan \u0111\u1ebfn FDA v\u00e0 b\u00e1o c\u00e1o t\u00e0i ch\u00ednh."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o GALT l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao, kh\u1ea3 n\u0103ng FDA t\u1eeb ch\u1ed1i ph\u00ea duy\u1ec7t belapectin, y\u00eau c\u1ea7u th\u1eed nghi\u1ec7m b\u1ed5 sung l\u00e0m t\u0103ng chi ph\u00ed, v\u00e0 ph\u1ee5 thu\u1ed9c t\u00e0i ch\u00ednh v\u00e0o ngu\u1ed3n v\u1ed1n b\u00ean ngo\u00e0i do c\u00f4ng ty v\u1eabn \u0111ang l\u1ed7."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu GALT trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o \u0111\u1ebfn cu\u1ed1i n\u0103m 2025 l\u00e0 $6.00 v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng 46% n\u1ebfu FDA ph\u00ea duy\u1ec7t th\u00e0nh c\u00f4ng. Tuy nhi\u00ean, gi\u00e1 c\u00f3 th\u1ec3 gi\u1ea3m n\u1ebfu c\u00f3 tr\u00ec ho\u00e3n ho\u1eb7c th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m, v\u00e0 r\u1ea5t bi\u1ebfn \u0111\u1ed9ng trong d\u00e0i h\u1ea1n v\u1edbi ph\u1ea1m vi t\u1eeb $0.50 \u0111\u1ebfn tr\u00ean $20 t\u00f9y k\u1ebft qu\u1ea3 th\u01b0\u01a1ng m\u1ea1i."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o GALT?","answer":"Pocket Option c\u00f3 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p ch\u1ec9 $5, quy tr\u00ecnh x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n \u0111a d\u1ea1ng v\u00e0 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi mu\u1ed1n th\u1eed nghi\u1ec7m \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 GALT."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 gi\u1ea3m thi\u1ec3u r\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GALT?","answer":"B\u1ea1n n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf, \u00e1p d\u1ee5ng chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1, \u0111\u1eb7t l\u1ec7nh c\u1eaft l\u1ed7 15-20%, v\u00e0 theo d\u00f5i s\u00e1t c\u00e1c tin t\u1ee9c quan tr\u1ecdng nh\u01b0 n\u1ed9p h\u1ed3 s\u01a1 FDA v\u00e0 b\u00e1o c\u00e1o t\u00e0i ch\u00ednh \u0111\u1ec3 \u0111i\u1ec1u ch\u1ec9nh chi\u1ebfn l\u01b0\u1ee3c k\u1ecbp th\u1eddi."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu GALT th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n h\u1ed7 tr\u1ee3 NASDAQ. H\u00e3y ch\u1ecdn n\u1ec1n t\u1ea3ng uy t\u00edn, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu \"GALT\", \u0111\u1eb7t l\u1ec7nh mua v\u1edbi lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 theo d\u00f5i c\u00e1c tin t\u1ee9c li\u00ean quan \u0111\u1ebfn FDA v\u00e0 b\u00e1o c\u00e1o t\u00e0i ch\u00ednh."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o GALT l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m bi\u1ebfn \u0111\u1ed9ng gi\u00e1 cao, kh\u1ea3 n\u0103ng FDA t\u1eeb ch\u1ed1i ph\u00ea duy\u1ec7t belapectin, y\u00eau c\u1ea7u th\u1eed nghi\u1ec7m b\u1ed5 sung l\u00e0m t\u0103ng chi ph\u00ed, v\u00e0 ph\u1ee5 thu\u1ed9c t\u00e0i ch\u00ednh v\u00e0o ngu\u1ed3n v\u1ed1n b\u00ean ngo\u00e0i do c\u00f4ng ty v\u1eabn \u0111ang l\u1ed7."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu GALT trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o \u0111\u1ebfn cu\u1ed1i n\u0103m 2025 l\u00e0 $6.00 v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng 46% n\u1ebfu FDA ph\u00ea duy\u1ec7t th\u00e0nh c\u00f4ng. Tuy nhi\u00ean, gi\u00e1 c\u00f3 th\u1ec3 gi\u1ea3m n\u1ebfu c\u00f3 tr\u00ec ho\u00e3n ho\u1eb7c th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m, v\u00e0 r\u1ea5t bi\u1ebfn \u0111\u1ed9ng trong d\u00e0i h\u1ea1n v\u1edbi ph\u1ea1m vi t\u1eeb $0.50 \u0111\u1ebfn tr\u00ean $20 t\u00f9y k\u1ebft qu\u1ea3 th\u01b0\u01a1ng m\u1ea1i."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o GALT?","answer":"Pocket Option c\u00f3 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p ch\u1ec9 $5, quy tr\u00ecnh x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n \u0111a d\u1ea1ng v\u00e0 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi mu\u1ed1n th\u1eed nghi\u1ec7m \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 GALT."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 gi\u1ea3m thi\u1ec3u r\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GALT?","answer":"B\u1ea1n n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf, \u00e1p d\u1ee5ng chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1, \u0111\u1eb7t l\u1ec7nh c\u1eaft l\u1ed7 15-20%, v\u00e0 theo d\u00f5i s\u00e1t c\u00e1c tin t\u1ee9c quan tr\u1ecdng nh\u01b0 n\u1ed9p h\u1ed3 s\u01a1 FDA v\u00e0 b\u00e1o c\u00e1o t\u00e0i ch\u00ednh \u0111\u1ec3 \u0111i\u1ec1u ch\u1ec9nh chi\u1ebfn l\u01b0\u1ee3c k\u1ecbp th\u1eddi."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T13:58:43+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)\",\"datePublished\":\"2025-08-25T13:58:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"datePublished\":\"2025-08-25T13:58:43+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T13:58:43+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)","datePublished":"2025-08-25T13:58:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","datePublished":"2025-08-25T13:58:43+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals10.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Galectin Therapeutics Inc. (GALT)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":348120,"slug":"how-to-buy-galectin-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Galectin Therapeutics Inc. (GALT) - Investimento em a\u00e7\u00f5es da Galectin Therapeutics Inc. (GALT)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-galectin-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/348122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=348122"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/348122\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334072"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=348122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=348122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=348122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}